Safety and tolerability of the bolus 5-fluorouracil (5-FU) based FLOX and IFL regimens in patients who developed fluoropyrimidine-induced coronary vasospasm during therapy with infusional 5-FU or capecitabine.

Sakti Chakrabarti,Jaskanwal D. Sara,Ronstan Lobo,Rachel Eiring,Heidi D. Finnes,Jessica L Mitchelll,Mindy L. Hartgers,Akiko Okano,Thorvardur R. Halfdanarson,Axel F Grothey

Safety and tolerability of the bolus 5-fluorouracil (5-FU) based FLOX and IFL regimens in patients who developed fluoropyrimidine-induced coronary vasospasm during therapy with infusional 5-FU or capecitabine.

2018

Sakti Chakrabarti
Jaskanwal D. Sara
Ronstan Lobo
Rachel Eiring
Heidi D. Finnes
Jessica L Mitchelll
Mindy L. Hartgers
Akiko Okano
Thorvardur R. Halfdanarson
Axel F Grothey

e15513Background: Coronary vasospasm associated with 5-FU based chemotherapy regimens is well described in the literature and has been reported to occur more often with infusional 5-FU or capecitab...

Keywords:

Capecitabine
Bolus (digestion)
Physical therapy
Coronary vasospasm
Fluorouracil
FLOX
Cardiology
Medicine
Tolerability
Internal medicine
Chemotherapy
Oncology
in patient
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations